Corpus Intelligence IC Memo — HORIZON MEDICAL CENTER 2026-04-26 06:40 UTC
IC Memo — HORIZON MEDICAL CENTER
Investment Committee Memorandum | TN | 96 beds | Grade C | EBITDA uplift $10.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HORIZON MEDICAL CENTER

CCN 440046 | nan, TN | 96 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HORIZON MEDICAL CENTER is a 96-bed suburban community hospital in nan, TN with $141.3M in net patient revenue and a 15.3% operating margin. The hospital serves a payer mix of 26.8% Medicare, 6.0% Medicaid, and 67.2% commercial.

Thesis: Turnaround. Our ML models identify $10.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.3% to 22.7% (+736bps).

Net Revenue HCRIS$141.3M
Current EBITDA COMPUTED$21.7M
Operating Margin COMPUTED15.3%
Occupancy HCRIS74.6%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS13.1%
Distress Probability ML40.7%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
55
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 15.3% places it above the state median. Among 55 size-comparable peers (48-192 beds), the median margin is 1.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (48-192), prioritizing same-state peers. 55 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HORIZON MEDICAL CENTER (Target)TN96$141.3M15.3%
BLOUNT MEMORIAL HOSPITALTN145$326.0M-8.5%
SUMMIT MEDICAL CENTERTN188$298.0M40.6%
METRO NASHVILLE GENERAL HOSPITTN114$287.4M48.9%
TRISTAR HENDERSONVILLE MEDICALTN129$208.6M41.5%
TRISTAR STONECREST MEDICAL CENTN115$190.0M39.5%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
SKYRIDGE MEDICAL CENTERTN176$163.5M17.3%
SUMNER REGIONAL MEDICAL CENTERTN138$161.9M-2.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.0M+210bp18mo
Cost to Collect4.5%2.5%$2.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.7M+122bp9mo
Clean Claim Rate88.0%96.0%$90K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.0M
Cost to Collect
$2.8M
Denial Rate Reduction
$2.8M
A/R Days Reduction
$1.7M
Clean Claim Rate
$90K
Total EBITDA Uplift$10.4M
Current EBITDA$21.7M
+ RCM Uplift+$10.4M
Pro Forma EBITDA$32.1M
Current Margin15.3%
Pro Forma Margin22.7%
WC Released (1x)$5.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$33.3M$247.0M7.41x49.3%
Base (11x exit)10.0x11.0x$33.3M$282.5M8.47x53.3%
Bull Case9.0x11.0x$30.0M$327.7M10.92x61.3%
Bull (12x exit)9.0x12.0x$30.0M$366.3M12.21x64.9%
Bear Case11.0x10.0x$36.7M$184.2M5.02x38.1%
Bear (11x exit)11.0x11.0x$36.7M$214.5M5.85x42.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 55 hospitals with 48-192 beds
  • Same-state prioritization (n=56)
  • Comp margins: P25=-8.3% / P50=1.7% / P75=13.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.